| Mankind Pharma Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
543904
ISIN Demat:
INE634S01028
Book Value(₹): 354.72 NSE Symbol:
MANKIND
Div & Yield(%):
N.A
Market Cap(₹ Cr): 105,753.00 P/E(TTM):
58.43
EPS(TTM):
43.85
Face Value(₹): 1.00 |
| Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | Dec 21 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 9,497.80 | 8,629.25 | 8,127.15 | 7,486.22 | 5,523.18 |
| Other Income | 554.44 | 374.03 | 162.78 | 203.81 | 154.50 |
| Stock Adjustments | 13.50 | 48.20 | -267.89 | 365.27 | 254.25 |
| Total Income | 10,065.74 | 9,051.48 | 8,022.04 | 8,055.30 | 5,931.93 |
| EXPENDITURE : | |||||
| Raw Materials | 2,610.39 | 2,618.31 | 2,576.87 | 2,886.71 | 2,036.42 |
| Power and Fuel Cost | 88.97 | 80.91 | 62.00 | 60.36 | 47.16 |
| Other Manufacturing Expenses | 203.70 | 145.78 | 113.62 | 93.57 | 56.71 |
| Selling and Administration Expenses | 1,770.41 | 1,518.78 | 1,539.07 | 1,378.52 | 905.53 |
| Miscellaneous Expenses | 143.09 | 125.69 | 168.47 | 131.08 | 192.07 |
| Employee Benefit Expenses | 2,131.67 | 1,921.09 | 1,701.38 | 1,462.76 | 1,167.42 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 3,117.51 | 2,640.92 | 1,860.65 | 2,042.30 | 1,526.62 |
| Interest | 372.28 | 16.93 | 28.23 | 47.54 | 8.23 |
| Gross Profit | 2,745.23 | 2,623.99 | 1,832.42 | 1,994.76 | 1,518.39 |
| Depreciation | 378.01 | 335.26 | 269.58 | 123.33 | 78.19 |
| Profit Before Tax | 2,367.22 | 2,288.73 | 1,562.84 | 1,871.43 | 1,440.20 |
| Current Tax | 469.93 | 411.33 | 291.64 | 429.03 | 346.99 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -48.19 | 1.24 | 22.94 | 52.98 | 8.84 |
| Reported Net Profit | 1,945.48 | 1,876.16 | 1,248.26 | 1,389.42 | 1,084.37 |
| Extraordinary Items | 254.30 | 105.89 | 29.02 | 62.07 | 30.09 |
| Adjusted Net Profit | 1,691.18 | 1,770.27 | 1,219.24 | 1,327.35 | 1,054.28 |
| Adjustment below Net Profit | 4.98 | -6.66 | -4.86 | -0.79 | -1.56 |
| Profit/Loss Balance carried down | 9,763.97 | 7,894.47 | 6,624.90 | 5,236.27 | 3,747.13 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 11,714.43 | 9,763.97 | 7,868.30 | 6,624.90 | 4,829.95 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 47.15 | 46.83 | 31.16 | 34.68 | 27.07 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 354.83 | 242.21 | 194.31 | 163.27 | 118.18 |
| Book Value(Adj)-Unit Curr | 354.83 | 242.21 | - | - | - |
